- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
Posted on 3/25/26 at 11:14 am to bayoubengals88
I’m not Ancient Tiger 
Posted on 3/25/26 at 11:20 am to ATLsuTiger
quote:
I’m not Ancient Tiger
Posted on 3/27/26 at 1:21 pm to ATLsuTiger
Bump for those that missed this.
Snag a few at the level and sit on them.
Gap to fill at $4.30 then just a massive hole up at $11.30
Fair value is at least $8 imo
Snag a few at the level and sit on them.
Gap to fill at $4.30 then just a massive hole up at $11.30
Fair value is at least $8 imo
This post was edited on 3/27/26 at 1:23 pm
Posted on 3/27/26 at 1:58 pm to ATLsuTiger
So Q1 guidance can be made up for.
What about the shelf offering?
35m cash currently represents more than 1/4 of current market cap.
Why do they need more?
What's it going to take for P/S to be closer to 1.5 to 2 so that share price get's closer to $8-10?
What about the shelf offering?
35m cash currently represents more than 1/4 of current market cap.
Why do they need more?
What's it going to take for P/S to be closer to 1.5 to 2 so that share price get's closer to $8-10?
Posted on 3/27/26 at 2:07 pm to ATLsuTiger
Damn... ok...
Why the "Bulls" see a "Massive Hole"
The reason people are screaming "Fair Value $8" or "Target $11" is that the Business Fundamentals (Revenue, Margins, EBITDA) are better now than they were in 2021, but the Market Cap is 85% lower.
2021: $1.1 Billion Market Cap on $75M Revenue (Trading at 14x Sales).
2026: $130 Million Market Cap on $105M Revenue (Trading at 1.2x Sales).
The "Baggage" is mostly cleared. The debt is lower, the FDA is happy, and they are EBITDA positive. The only thing missing is investor trust, which was shattered by that 1-for-14 split and the 2021 recall.
Why the "Bulls" see a "Massive Hole"
The reason people are screaming "Fair Value $8" or "Target $11" is that the Business Fundamentals (Revenue, Margins, EBITDA) are better now than they were in 2021, but the Market Cap is 85% lower.
2021: $1.1 Billion Market Cap on $75M Revenue (Trading at 14x Sales).
2026: $130 Million Market Cap on $105M Revenue (Trading at 1.2x Sales).
The "Baggage" is mostly cleared. The debt is lower, the FDA is happy, and they are EBITDA positive. The only thing missing is investor trust, which was shattered by that 1-for-14 split and the 2021 recall.
Posted on 3/27/26 at 2:21 pm to ATLsuTiger
quote:I just realized that you probably know more about OWLT than any retail investor on this planet.
ATLsuTiger
I really hope this works out for you.
Posted on 3/30/26 at 10:16 am to bayoubengals88
Rebuilding my position here.
5k shares and back in the game.
Posted on 3/30/26 at 1:45 pm to ATLsuTiger
I bought 4000 shares of this. I don't think it can get much worse. Good entry point.
Posted on 4/6/26 at 4:31 pm to Sgt_Lincoln_Osiris
Kurt is back baby!!!
Owlet Announces CEO Transition; Board Reaffirms Q1 2026 Guidance and Long-Term Growth Opportunity
Ready to double down here!
Owlet Announces CEO Transition; Board Reaffirms Q1 2026 Guidance and Long-Term Growth Opportunity
Ready to double down here!
Posted on 4/9/26 at 10:11 am to ATLsuTiger
This will be the easiest gap fill play of the year.


Posted on 4/14/26 at 12:42 pm to ATLsuTiger
Keep an eye on this one!
Projecting $130m in 2026 revenue. Straight up undervalued at this level.
Getting m&a vibes as well.
Projecting $130m in 2026 revenue. Straight up undervalued at this level.
Getting m&a vibes as well.
Posted on 4/14/26 at 1:11 pm to ATLsuTiger
I bought some, I mean it's up but the whole market is up. Will hold longer.
Posted on 4/16/26 at 10:23 am to j1897
Bump.
Do some DD and jump in before the gap fill runup.
Do some DD and jump in before the gap fill runup.
Posted on 4/16/26 at 10:34 am to ATLsuTiger
quote:Ok dammit!! I've done the DD. It's a clean setup and the chart looks good.
Do some DD and jump in before the gap fill runup.
Posted on 4/16/26 at 10:40 am to ATLsuTiger
It’s cheap on the revenue expectations but what’s your take on profitability?
Seems like it’s fits and starts there.
Seems like it’s fits and starts there.
Posted on 4/16/26 at 10:51 am to LSUcam7
Let me know what you think about this ATL in response to Cam:
I. THE TRANSITION TO MEDICAL GRADE CREDIBILITY
The cornerstone of Owlet's strategy involves shifting from being a consumer electronics brand to a recognized medical technology company. After receiving FDA clearances for the Dream Sock and BabySat, the company gained the ability to market its products as clinical tools rather than just wellness gadgets. This opens the door to the medical channel, where products can be prescribed by doctors and, crucially, covered by insurance or paid for via HSA/FSA funds. This reduces the price barrier for parents and creates a more professional, reliable brand image that justifies a premium price point.
II. OPERATIONAL RESTRUCTURING AND COST CONTROL
To hit profitability, Owlet has focused heavily on slimming down its operating expenses. This included significant workforce reductions and a more disciplined approach to marketing spend. Historically, the company burned cash to acquire customers in a crowded retail market. The new path focuses on higher-margin sales and a more efficient supply chain. By keeping overhead low and improving the gross margins on their hardware, they aim to reach a break-even point even if sales volume remains moderate.
III. SOLVING THE LUMPINESS: RECURRING REVENUE
The biggest challenge for any hardware company is the one and done sales cycle. To move from lumpy retail quarters to a steady stream of income, Owlet is pushing its subscription services. By offering enhanced features, long-term data tracking, and expert parenting content through their app, they turn a single hardware purchase into a multi-year financial relationship. This software-as-a-service (SaaS) model provides the predictable, high-margin monthly revenue that investors prefer over the volatility of seasonal retail.
IV. EXPANDING THE CARE CYCLE
Another move toward stability is extending the lifespan of the customer relationship. Instead of just monitoring an infant for the first six months, Owlet is developing products and software that track health and sleep through the toddler years. By broadening their ecosystem to include more than just the sock—such as integrated cameras and health platforms—they stay relevant to a family for years instead of months.
V. CLINICAL AND B2B PARTNERSHIPS
Moving away from a total reliance on big-box retailers like Target or Amazon is essential for stability. Owlet is increasingly looking toward partnerships with hospital systems and pediatric groups. When a hospital integrates Owlet’s technology into their discharge process or remote patient monitoring programs, it creates a steady, contractual flow of business that is far less sensitive to the whims of consumer spending habits or holiday shopping seasons.
Does this business-focused breakdown hit what you were looking for, or were you more interested in the specific stock performance and recent earnings numbers?
quote:
It’s cheap on the revenue expectations but what’s your take on profitability?
I. THE TRANSITION TO MEDICAL GRADE CREDIBILITY
The cornerstone of Owlet's strategy involves shifting from being a consumer electronics brand to a recognized medical technology company. After receiving FDA clearances for the Dream Sock and BabySat, the company gained the ability to market its products as clinical tools rather than just wellness gadgets. This opens the door to the medical channel, where products can be prescribed by doctors and, crucially, covered by insurance or paid for via HSA/FSA funds. This reduces the price barrier for parents and creates a more professional, reliable brand image that justifies a premium price point.
II. OPERATIONAL RESTRUCTURING AND COST CONTROL
To hit profitability, Owlet has focused heavily on slimming down its operating expenses. This included significant workforce reductions and a more disciplined approach to marketing spend. Historically, the company burned cash to acquire customers in a crowded retail market. The new path focuses on higher-margin sales and a more efficient supply chain. By keeping overhead low and improving the gross margins on their hardware, they aim to reach a break-even point even if sales volume remains moderate.
III. SOLVING THE LUMPINESS: RECURRING REVENUE
The biggest challenge for any hardware company is the one and done sales cycle. To move from lumpy retail quarters to a steady stream of income, Owlet is pushing its subscription services. By offering enhanced features, long-term data tracking, and expert parenting content through their app, they turn a single hardware purchase into a multi-year financial relationship. This software-as-a-service (SaaS) model provides the predictable, high-margin monthly revenue that investors prefer over the volatility of seasonal retail.
IV. EXPANDING THE CARE CYCLE
Another move toward stability is extending the lifespan of the customer relationship. Instead of just monitoring an infant for the first six months, Owlet is developing products and software that track health and sleep through the toddler years. By broadening their ecosystem to include more than just the sock—such as integrated cameras and health platforms—they stay relevant to a family for years instead of months.
V. CLINICAL AND B2B PARTNERSHIPS
Moving away from a total reliance on big-box retailers like Target or Amazon is essential for stability. Owlet is increasingly looking toward partnerships with hospital systems and pediatric groups. When a hospital integrates Owlet’s technology into their discharge process or remote patient monitoring programs, it creates a steady, contractual flow of business that is far less sensitive to the whims of consumer spending habits or holiday shopping seasons.
Does this business-focused breakdown hit what you were looking for, or were you more interested in the specific stock performance and recent earnings numbers?
This post was edited on 4/16/26 at 10:52 am
Posted on 4/16/26 at 11:01 am to bayoubengals88
I’ve been in and out of OWLT before. It’s many of the same financial issues it had back then before FDA approvals.
Honestly I had no idea the founder wasn’t CEO anymore. But to hear Workman is back.. it’s an interesting dice roll.
Honestly I had no idea the founder wasn’t CEO anymore. But to hear Workman is back.. it’s an interesting dice roll.
Popular
Back to top



1




